Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages
- PMID: 20181276
- PMCID: PMC2882220
- DOI: 10.1186/1476-072X-9-13
Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages
Abstract
Background: In Spring 2009, a novel reassortant strain of H1N1 influenza A emerged as a lineage distinct from seasonal H1N1. On June 11, the World Heath Organization declared a pandemic - the first since 1968. There are currently two main branches of H1N1 circulating in humans, a seasonal branch and a pandemic branch. The primary treatment method for pandemic and seasonal H1N1 is the antiviral drug Tamiflu (oseltamivir). Although many seasonal H1N1 strains around the world are resistant to oseltamivir, initially, pandemic H1N1 strains have been susceptible to oseltamivir. As of February 3, 2010, there have been reports of resistance to oseltamivir in 225 cases of H1N1 pandemic influenza. The evolution of resistance to oseltamivir in pandemic H1N1 could be due to point mutations in the neuraminidase or a reassortment event between seasonal H1N1 and pandemic H1N1 viruses that provide a neuraminidase carrying an oseltamivir-resistant genotype to pandemic H1N1.
Results: Using phylogenetic analysis of neuraminidase sequences, we show that both seasonal and pandemic lineages of H1N1 are evolving to direct selective pressure for resistance to oseltamivir. Moreover, seasonal lineages of H1N1 that are resistant to oseltamivir co-circulate with pandemic H1N1 throughout the globe. By combining phylogenetic and geographic data we have thus far identified 53 areas of co-circulation where reassortment can occur. At our website POINTMAP, http://pointmap.osu.edu we make available a visualization and an application for updating these results as more data are released.
Conclusions: As oseltamivir is a keystone of preparedness and treatment for pandemic H1N1, the potential for resistance to oseltamivir is an ongoing concern. Reassortment and, more likely, point mutation have the potential to create a strain of pandemic H1N1 against which we have a reduced number of treatment options.
Figures

Similar articles
-
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.J Clin Virol. 2010 Jan;47(1):34-7. doi: 10.1016/j.jcv.2009.09.030. Epub 2009 Oct 25. J Clin Virol. 2010. PMID: 19857993 Free PMC article.
-
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17. J Clin Virol. 2011. PMID: 21684202 Review.
-
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280. Emerg Infect Dis. 2009. PMID: 19331731 Free PMC article.
-
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.Euro Surveill. 2011 Jan 20;16(3):19770. Euro Surveill. 2011. PMID: 21262183
-
Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.Infect Disord Drug Targets. 2013 Feb;13(1):34-45. doi: 10.2174/18715265112129990006. Infect Disord Drug Targets. 2013. PMID: 23675925 Review.
Cited by
-
Risk factors for pandemic (H1N1) 2009 seroconversion among adults, Singapore, 2009.Emerg Infect Dis. 2011 Aug;17(8):1455-62. doi: 10.3201/eid1708.101270. Emerg Infect Dis. 2011. PMID: 21801623 Free PMC article.
-
Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic.Clin Microbiol Rev. 2012 Apr;25(2):344-61. doi: 10.1128/CMR.05016-11. Clin Microbiol Rev. 2012. PMID: 22491775 Free PMC article. Review.
-
Fundamentals of genomic epidemiology, lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, and new directions.Antimicrob Steward Healthc Epidemiol. 2021 Dec 7;1(1):e60. doi: 10.1017/ash.2021.222. eCollection 2021. Antimicrob Steward Healthc Epidemiol. 2021. PMID: 36168505 Free PMC article. Review.
-
Incorporation of a proteotyping approach using mass spectrometry for surveillance of influenza virus in cell-cultured strains.J Clin Microbiol. 2014 Mar;52(3):725-35. doi: 10.1128/JCM.02315-13. Epub 2013 Nov 13. J Clin Microbiol. 2014. PMID: 24226917 Free PMC article.
-
A geographic analysis of population density thresholds in the influenza pandemic of 1918-19.Int J Health Geogr. 2013 Feb 20;12:9. doi: 10.1186/1476-072X-12-9. Int J Health Geogr. 2013. PMID: 23425498 Free PMC article.
References
-
- WHO. Pandemic (H1N1) 2009 - update 58. 2009. http://www.who.int/csr/don/2009_07_06/en/index.html
-
- WHO. "Pandemic (H1N1) 2009 - update 83". http://www.who.int/csr/disease/swineflu/laboratory15_01_2010/en/index.html
-
- CDC. Oseltamivir-Resistant Novel Influenza A (H1N1) Virus Infection in Two Immunosuppressed Patients - Seattle, Washington, 2009. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0814a1.htm - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials